SSA
VERV

Schonfeld Strategic Advisors’s Verve Therapeutics VERV Stock Holding History

Schonfeld Strategic Advisors’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-176,281
Closed -$1.98M – 2622
2025
Q2 		$1.98M Sell
176,281
-2,747,137
-94% -$15.7M 0.01% 997
2025
Q1 		$13.4M Sell
2,923,418
-865,961
-23% -$5.8M 0.09% 248
2024
Q4 		$21.4M Buy
3,789,379
+1,382,176
+57% +$7.8M 0.13% 139
2024
Q3 		$11.7M Buy
+2,407,203
New +$14M 0.09% 256
2023
Q1 		– Sell
-51,640
Closed -$999K – 2690
2022
Q4 		$999K Buy
51,640
+28,627
+124% +$758K 0.01% 1151
2022
Q3 		$790K Sell
23,013
-2,368
-9% -$75.6K 0.01% 1445
2022
Q2 		$388K Buy
+25,381
New +$393K ﹤0.01% 1509

Other funds holding VERV

GCM
Greenland Capital Management New York $500M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return